What is the current stock price of Longboard Pharmaceuticals, Inc. (LBPH)?

As of the latest market data, Longboard Pharmaceuticals, Inc. (LBPH) is trading at $59.98. The stock has seen a loss of 0.00% today.

Does Longboard Pharmaceuticals, Inc. (LBPH) pay a dividend?

Based on current data, Longboard Pharmaceuticals, Inc. does not have a confirmed active dividend policy.

What is the market cap of Longboard Pharmaceuticals, Inc.?

The current market capitalization of Longboard Pharmaceuticals, Inc. (LBPH) is approximately unavailable.

LBPH

Longboard Pharmaceuticals, Inc.·Healthcare

59.98

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $59.9852W H: $59.98

Company Profile

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-03-12

Beta

1.09

Websitewww.longboardpharma.com↗